However, the presence of immune activating molecules on luminal BC cells is inherently rather low or does basically not exist [71], which means that a PROTAC-induced (further) decrease of CD276 and MHC-I would most likely not additionally alter the immunological invisibility of luminal BC cells. This evidence concerns the gene CD276 and breast cancer.